mRNA COVID vaccination tied to 80% lower risk of asymptomatic infection
https://www.cidrap.umn.edu/news-perspective/2021/03/covid-19-scan-mar-11-2021 mRNA COVID vaccination tied to 80% lower risk of asymptomatic infection A real-world Mayo Clinic study shows a link between vaccination with two doses of an mRNA-based COVID-19 vaccine—either…
CMS visitation Guidance update
QSO-20-39-NH Revised (cms.gov) According to the updated guidance, facilities should allow responsible indoor visitation at all times and for all residents, regardless of vaccination status of the resident, or visitor,…
Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19: A Randomized Clinical Trial | Infectious Diseases | JAMA | JAMA Network
Question What is the effect of ivermectin on duration of symptoms in adults with mild COVID-19? Findings In this randomized clinical trial that included 476 patients, the duration of symptoms…
JAMA: Acute Allergic Reactions to mRNA COVID-19 Vaccines
Research Letter March 8, 2021 Kimberly G. Blumenthal, MD, MSc1; Lacey B. Robinson, MD, MPH1; Carlos A. Camargo Jr, MD, DrPH2; et alErica S. Shenoy, MD, PhD3; Aleena Banerji, MD1;…
Ridgeback Biotherapeutics and Merck Announce Preliminary Findings from a Phase 2a Trial of Investigational COVID-19 Therapeutic Molnupiravir – Merck.com
https://www.merck.com/news/ridgeback-biotherapeutics-and-merck-announce-preliminary-findings-from-a-phase-2a-trial-of-investigational-covid-19-therapeutic-molnupiravir/
Medical Director Report 3-2021
Dr. Shepherd Medical Director Report 3-2021 Click Here for the Report CDPHE COVID-19 Update Presentation 2-24-2021
Colorado COVID-19 Variant Update March 5, 2021
See full health advisory update ● CDPHE has been conducting ongoing surveillance for COVID-19 variants since December 2020, when the first case of B.1.1.7 in Colorado was announced.● As of…
Is the End of the Long-Term Care Crisis Within Sight? New COVID-19 Cases and Deaths in Long-Term Care Facilities Are Dropping | KFF
Weekly new deaths among nursing home residents have decreased by 66% since long-term care vaccination efforts started at the end of December, compared to a 61% increase in all other…
J&J’s Covid-19 Vaccine Is Safe and Effective, FDA Says
The U.S. Food and Drug Administration found that Johnson & Johnson’s single-dose Covid-19 vaccine was 66.1% effective in preventing moderate to severe virus disease and appeared safe. The positive report…